ArticleBMC musculoskeletal disorders2025
Comparative analysis of ChatGPT-4o mini, ChatGPT-4o and Gemini Advanced in the treatment of postmenopausal osteoporosis.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Evaluation of large language model responses to patient questions on oral anticoagulant therapy: a comparative expert assessment.Exploratory research in clinical and social pharmacy · 2026Article
- Performance of Large Language Models in Answering Osteoporosis-Related Frequently Asked Questions: A Systematic Comparative Evaluation Based on International Associations.Calcified tissue international · 2026Article
- Comparative performance of ChatGPT-4o, ChatGPT-5, and gemini 2.5 flash on Persian internal medicine subspecialty board exams.Scientific reports · 2025Article
- Artificial Intelligence Chatbots in Pediatric Emergencies: A Reliable Lifeline or a Risk?Cureus · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOsteoporosis is a sex-specific disease. Postmenopausal osteoporosis (PMOP) has been the focus of public health research worldwide. The purpose of this study is to evaluate the quality and readability of artificial intelligence large-scale language models (AI-LLMs): ChatGPT-4o mini, ChatGPT-4o and Gemini Advanced for responses generated in response to questions related to PMOP.
methodsWe collected 48 PMOP frequently asked questions (FAQs) through offline counseling and online medical community forums. We also prepared 24 specific questions about PMOP based on the Management of Postmenopausal Osteoporosis: 2022 ACOG Clinical Practice Guideline No. 2 (2022 ACOG-PMOP Guideline). In this project, the FAQs were imported into the AI-LLMs (ChatGPT-4o mini, ChatGPT-4o, Gemini Advanced) and randomly assigned to four professional orthopedic surgeons, who independently rated the satisfaction of each response via a 5-point Likert scale. Furthermore, a Flesch Reading Ease (FRE) score was calculated for each of the LLMs' responses to assess the readability of the text generated by each LLM.
resultsWhen it comes to addressing questions related to PMOP and the 2022 ACOG-PMOP guidelines, ChatGPT-4o and Gemini Advanced provide more concise answers than ChatGPT-4o mini. In terms of the overall FAQs of PMOP, ChatGPT-4o has a significantly higher accuracy rate than ChatGPT-4o mini and Gemini Advanced. When answering questions related to the 2022 ACOG-PMOP guidelines, ChatGPT-4o mini vs. ChatGPT-4o have significantly higher response accuracy than Gemini Advanced. ChatGPT-4o mini, ChatGPT-4o, and Gemini Advanced all have good levels of self-correction.
conclusionsOur research shows that Gemini Advanced and ChatGPT-4o provide more concise and intuitive answers. ChatGPT-4o responds better in answering frequently asked questions related to PMOP. When answering questions related to the 2022 ACOG-PMOP guidelines, ChatGPT-4o mini and ChatGPT-4o responded significantly better than Gemini Advanced. ChatGPT-4o mini, ChatGPT-4o, and Gemini Advanced have demonstrated a strong ability to self-correct. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.